Vascular Endothelial Growth Factor (VEGF)-D Stimulates VEGF-A, Stanniocalcin-1, and Neuropilin-2 and Has Potent Angiogenic Effects
- 1 July 2011
- journal article
- research article
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 31 (7) , 1617-1624
Abstract
Objective—: The mature form of human vascular endothelial growth factor-D (hVEGF-D ΔNΔC ) is an efficient angiogenic factor, but its full mechanism of action has remained unclear. We studied the effects of hVEGF-D ΔNΔC in endothelial cells using gene array, signaling, cell culture, and in vivo gene transfer techniques. Methods and Results—: Concomitant with the angiogenic and proliferative responses, hVEGF-D ΔNΔC enhanced the phosphorylation of VEGF receptor-2, Akt, and endothelial nitric oxide synthase. Gene arrays, quantitative reverse transcription–polymerase chain reaction, and Western blot revealed increases in VEGF-A, stanniocalcin-1 (STC1), and neuropilin (NRP) 2 expression by hVEGF-D ΔNΔC stimulation, whereas induction with hVEGF-A 165 altered the expression of STC1 and NRP1, another coreceptor for VEGFs. The effects of hVEGF-D ΔNΔC were seen only under high-serum conditions, whereas for hVEGF-A 165 , the strongest response was observed under low-serum conditions. The hVEGF-D ΔNΔC -induced upregulation of STC1 and NRP2 was also evident in vivo in mouse skeletal muscle treated with hVEGF-D ΔNΔC by adenoviral gene delivery. The importance of NRP2 in hVEGF-D ΔNΔC signaling was further studied with NRP2 small interfering RNA and NRP antagonist, which were able to block hVEGF-D ΔNΔC -induced survival of endothelial cells. Conclusion—: In this study, the importance of serum and upregulation of NRP2 and STC1 for VEGF-D ΔNΔC effects were demonstrated. Better knowledge of VEGF-D ΔNΔC signaling and regulation is valuable for the development of efficient and safe VEGF-D ΔNΔC -based therapeutic applications for cardiovascular diseases.Keywords
This publication has 46 references indexed in Scilit:
- Vascular Endothelial Growth FactorsJACC, 2007
- Proprotein convertases promote processing of VEGF‐D, a critical step for binding the angiogenic receptor VEGFR‐2The FASEB Journal, 2007
- The biology of vascular endothelial growth factorsCardiovascular Research, 2005
- Plasmin Activates the Lymphangiogenic Growth Factors VEGF-C and VEGF-DJournal of Experimental Medicine, 2003
- Gene transfer as a tool to induce therapeutic vascular growthNature Medicine, 2003
- The biology of VEGF and its receptorsNature Medicine, 2003
- In Fibroblasts Vegf-D Expression Is Induced by Cell-Cell Contact Mediated by Cadherin-11Journal of Biological Chemistry, 2001
- Biosynthesis of Vascular Endothelial Growth Factor-D Involves Proteolytic Processing Which Generates Non-covalent HomodimersJournal of Biological Chemistry, 1999
- Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4)Proceedings of the National Academy of Sciences, 1998
- Identification of a c-fos-induced gene that is related to the platelet-derived growth factor/vascular endothelial growth factor family.Proceedings of the National Academy of Sciences, 1996